aTyr Pharma to Present at Upcoming Investor Conferences
Details of the conferences appear below:
Conference:
Date:
Time:
Location:
Format: Corporate Presentation
Conference:
Date:
Time:
Location:
Format: Corporate Presentation
Conference: 7th Annual
Date:
Time:
Location:
Format: Fireside Chat
Conference: Piper Sandler 36th Annual Healthcare Conference
Date:
Time:
Location:
Format: Fireside Chat
In addition to the presentations, company management will be available to participate in one-on-one meetings with investors who are registered attendees of the conferences. A webcast of the presentations will be available on the Investor’s section of the company’s website at www.atyrpharma.com. Following the events, a replay of the presentations will be available on the aTyr website for at least 90 days. For more information, contact investorrelations@atyrpharma.com.
About aTyr
aTyr is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. tRNA synthetases are ancient, essential proteins that have evolved novel domains that regulate diverse pathways extracellularly in humans. aTyr’s discovery platform is focused on unlocking hidden therapeutic intervention points by uncovering signaling pathways driven by its proprietary library of domains derived from all 20 tRNA synthetases. aTyr’s lead therapeutic candidate is efzofitimod, a first-in-class biologic immunomodulator in clinical development for the treatment of interstitial lung disease, a group of immune-mediated disorders that can cause inflammation and progressive fibrosis, or scarring, of the lungs. For more information, please visit www.atyrpharma.com.
| Contact: |
| Director, Investor Relations and Public Affairs |
| adunston@atyrpharma.com |
Source: aTyr Pharma, Inc.